Pierre‐François Meyer

1.4k total citations
19 papers, 282 citations indexed

About

Pierre‐François Meyer is a scholar working on Physiology, Psychiatry and Mental health and Molecular Biology. According to data from OpenAlex, Pierre‐François Meyer has authored 19 papers receiving a total of 282 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Physiology, 8 papers in Psychiatry and Mental health and 4 papers in Molecular Biology. Recurrent topics in Pierre‐François Meyer's work include Alzheimer's disease research and treatments (9 papers), Dementia and Cognitive Impairment Research (8 papers) and S100 Proteins and Annexins (4 papers). Pierre‐François Meyer is often cited by papers focused on Alzheimer's disease research and treatments (9 papers), Dementia and Cognitive Impairment Research (8 papers) and S100 Proteins and Annexins (4 papers). Pierre‐François Meyer collaborates with scholars based in Canada, United States and United Kingdom. Pierre‐François Meyer's co-authors include Judes Poirier, John C.S. Breitner, Pedro Rosa‐Neto, Mélissa Savard, Sylvia Villeneuve, Melissa McSweeney, Julie Gonneaud, Anne Labonté, Jennifer Tremblay‐Mercier and Alexa Pichet Binette and has published in prestigious journals such as NeuroImage, Neurology and Acta Psychiatrica Scandinavica.

In The Last Decade

Pierre‐François Meyer

19 papers receiving 280 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Pierre‐François Meyer Canada 9 166 99 86 40 35 19 282
Hairong Liao China 5 127 0.8× 77 0.8× 70 0.8× 86 2.1× 35 1.0× 9 337
Nancy J. Davenport‐Sis United States 3 155 0.9× 72 0.7× 94 1.1× 36 0.9× 14 0.4× 4 258
Maryline Simon Switzerland 5 197 1.2× 175 1.8× 74 0.9× 46 1.1× 16 0.5× 13 298
Di Yu Canada 10 108 0.7× 61 0.6× 117 1.4× 61 1.5× 50 1.4× 13 406
Naira Goukasian United States 12 209 1.3× 160 1.6× 49 0.6× 79 2.0× 20 0.6× 23 365
Sarah Westwood United Kingdom 7 183 1.1× 144 1.5× 44 0.5× 103 2.6× 20 0.6× 8 324
Patrick M. Dooley United States 4 241 1.5× 37 0.4× 78 0.9× 103 2.6× 19 0.5× 4 356
Joshua Stevenson‐Hoare United Kingdom 8 138 0.8× 92 0.9× 53 0.6× 108 2.7× 11 0.3× 15 335
Kazumasa Kume Japan 8 131 0.8× 116 1.2× 67 0.8× 61 1.5× 7 0.2× 9 313
Le Gjerum Denmark 7 102 0.6× 103 1.0× 42 0.5× 20 0.5× 11 0.3× 24 279

Countries citing papers authored by Pierre‐François Meyer

Since Specialization
Citations

This map shows the geographic impact of Pierre‐François Meyer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pierre‐François Meyer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pierre‐François Meyer more than expected).

Fields of papers citing papers by Pierre‐François Meyer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pierre‐François Meyer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pierre‐François Meyer. The network helps show where Pierre‐François Meyer may publish in the future.

Co-authorship network of co-authors of Pierre‐François Meyer

This figure shows the co-authorship network connecting the top 25 collaborators of Pierre‐François Meyer. A scholar is included among the top collaborators of Pierre‐François Meyer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pierre‐François Meyer. Pierre‐François Meyer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Ashton, Nicholas J., Cherie Strikwerda‐Brown, Laia Montoliu‐Gaya, et al.. (2023). Longitudinal blood biomarker trajectories in preclinical Alzheimer's disease. Alzheimer s & Dementia. 19(12). 5620–5631. 32 indexed citations
2.
Ashton, Nicholas J., Thomas K. Karikari, Cherie Strikwerda‐Brown, et al.. (2022). Longitudinal Blood Biomarker Trajectories in Preclinical Alzheimer’s Disease. Alzheimer s & Dementia. 18(S1). 4 indexed citations
3.
Köbe, Theresa, Alexa Pichet Binette, Jacob W. Vogel, et al.. (2021). Vascular risk factors are associated with a decline in resting-state functional connectivity in cognitively unimpaired individuals at risk for Alzheimer's disease. NeuroImage. 231. 117832–117832. 13 indexed citations
4.
Nilsson, Nathalie, Cynthia Picard, Anne Labonté, et al.. (2021). Association of a Total Cholesterol Polygenic Score with Cholesterol Levels and Pathological Biomarkers across the Alzheimer’s Disease Spectrum. Genes. 12(11). 1805–1805. 4 indexed citations
5.
Peters, Ruth, Hiroko H. Dodge, Sarah‐Naomi James, et al.. (2021). The epidemiology is promising, but the trial evidence is weak. Why pharmacological dementia risk reduction trials haven't lived up to expectations, and where do we go from here?. Alzheimer s & Dementia. 18(3). 507–512. 9 indexed citations
6.
Peters, Ruth, John C.S. Breitner, Sarah‐Naomi James, et al.. (2021). Dementia risk reduction: why haven't the pharmacological risk reduction trials worked? An in‐depth exploration of seven established risk factors. Alzheimer s & Dementia Translational Research & Clinical Interventions. 7(1). e12202–e12202. 3 indexed citations
7.
Köbe, Theresa, Julie Gonneaud, Alexa Pichet Binette, et al.. (2020). Association of Vascular Risk Factors With β-Amyloid Peptide and Tau Burdens in Cognitively Unimpaired Individuals and Its Interaction With Vascular Medication Use. JAMA Network Open. 3(2). e1920780–e1920780. 33 indexed citations
8.
McSweeney, Melissa, Alexa Pichet Binette, Pierre‐François Meyer, et al.. (2020). Intermediate flortaucipir uptake is associated with Aβ-PET and CSF tau in asymptomatic adults. Neurology. 94(11). e1190–e1200. 26 indexed citations
9.
Meyer, Pierre‐François, Jennifer Tremblay‐Mercier, Jeannie‐Marie Leoutsakos, et al.. (2019). INTREPAD. Neurology. 92(18). e2070–e2080. 80 indexed citations
10.
Meyer, Pierre‐François, Anne Labonté, Pedro Rosa‐Neto, Judes Poirier, & John C.S. Breitner. (2019). No apparent effect of naproxen onCSFmarkers of innate immune activation. Annals of Clinical and Translational Neurology. 6(6). 1127–1133. 7 indexed citations
11.
Meyer, Pierre‐François, Melissa McSweeney, Julie Gonneaud, & Sylvia Villeneuve. (2019). AD molecular: PET amyloid imaging across the Alzheimer's disease spectrum: From disease mechanisms to prevention. Progress in molecular biology and translational science. 165. 63–106. 11 indexed citations
12.
Meyer, Pierre‐François, et al.. (2019). Hypothesis: cerebrospinal fluid protein markers suggest a pathway toward symptomatic resilience to AD pathology. Alzheimer s & Dementia. 15(9). 1160–1171. 12 indexed citations
13.
Meyer, Pierre‐François, Mélissa Savard, Judes Poirier, et al.. (2018). Bi-directional Association of Cerebrospinal Fluid Immune Markers with Stage of Alzheimer’s Disease Pathogenesis. Journal of Alzheimer s Disease. 63(2). 577–590. 32 indexed citations
14.
McSweeney, Melissa, Alexa Pichet Binette, Pierre‐François Meyer, et al.. (2018). O1‐03‐06: EARLY INCREASE IN TAU‐PET SIGNAL IS ASSOCIATED WITH Aβ BURDEN, CSF P‐TAU LEVELS AND COGNITION IN COGNITIVELY NORMAL LATE‐MIDDLE‐AGED ADULTS. Alzheimer s & Dementia. 14(7S_Part_4). 1 indexed citations
15.
Link, H., F. Herrmann, Walter E. Aulitzky, et al.. (1994). [Rational therapy with G-CSF and GM-CSF].. PubMed. 89(8). 429–41. 3 indexed citations
16.
Meyer, Pierre‐François, et al.. (1987). [Renal manifestations in dermatomyositis and polymyositis].. PubMed. 138(2). 109–13. 4 indexed citations
17.
Ichaï, Carole, et al.. (1987). [Treatment of poisoning caused by new anti-arrhythmia agents (cibenzoline, flecainide and propafenone)].. PubMed. 16(41). 2076–2076. 3 indexed citations
18.
Meyer, Pierre‐François, et al.. (1966). Obesity and the Aging of the Human Adrenal Cortex. Gerontologia Clinica. 8(6). 370–376. 2 indexed citations
19.
Broman, Tore, et al.. (1960). INVESTIGATIONS OF MULTIPLE SCLEROSIS PATIENTS CONCERNING SKIN AND SEROLOGICAL REACTIONS TO INJECTIONS WITH BRAIN TISSUE. Acta Psychiatrica Scandinavica. 35(4). 403–413. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hairong Liao Breakdown of academic impact, for papers by Nancy J. Davenport‐Sis Breakdown of academic impact, for papers by Maryline Simon Breakdown of academic impact, for papers by Di Yu Breakdown of academic impact, for papers by Naira Goukasian Breakdown of academic impact, for papers by Sarah Westwood Breakdown of academic impact, for papers by Patrick M. Dooley Breakdown of academic impact, for papers by Joshua Stevenson‐Hoare Breakdown of academic impact, for papers by Kazumasa Kume Breakdown of academic impact, for papers by Le Gjerum
Rankless by CCL
2026